Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 May 9;46(6):e70685. doi: 10.1111/liv.70685

Correction to ‘Durvalumab–Tremelimumab in Advanced Hepatocellular Carcinoma: Real‐World Data From the LOR‐HCC (Lombardy Real‐World HCC Group)’

PMCID: PMC13484129  PMID: 42104848

A. Casadei‐Gardini, L. Canova, F. Tosi, et al., ‘Durvalumab–Tremelimumab in Advanced Hepatocellular Carcinoma: Real‐World Data From the LOR‐HCC (Lombardy Real‐World HCC Group)’, Liver International 46, no. 5 (2026): e70640, https://doi.org/10.1111/liv.70640

The affiliations of the author Salvatore Corallo were incorrect in the published version. His correct affiliations are:

1. Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy

2. Unit of Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

We apologise for this error.


Articles from Liver International are provided here courtesy of Wiley

RESOURCES